US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist

10.060
+0.060+0.60%

Trading Jun 10 11:19 ET

84.64MMarket Cap-167666P/E (TTM)

Serina Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

-83.55%500K

3.04M

Operating revenue

--0

-83.55%500K

--3.04M

Cost of revenue

Gross profit

Operating expense

141.27%2.32M

945.54K

962K

-40.69%2.77M

4.67M

Selling and administrative expenses

105.73%1.22M

--473.36K

--593K

-0.68%1.29M

--1.3M

-General and administrative expense

105.73%1.22M

--473.36K

--593K

-0.68%1.29M

--1.3M

Research and development costs

177.19%1.11M

--479.19K

--399K

-58.59%1.57M

--3.8M

Other operating expenses

83.33%-5K

---7K

---30K

78.50%-91.5K

---425.57K

Operating profit

-141.27%-2.32M

-945.54K

-962K

-39.16%-2.27M

-1.63M

Net non-operating interest income expense

-15.12%-99K

-107.63K

-86K

-281.85%-14.12K

7.77K

Non-operating interest income

----

-83.82%1.76K

--10.86K

Non-operating interest expense

15.12%99K

--195.7K

--86K

413.19%15.88K

--3.09K

Other net income (expense)

-359.31%-7.02M

1.86M

2.71M

-210.75%-397.62K

359.04K

Gain on sale of security

-359.31%-7.02M

--1.86M

--2.71M

-300.52%-398.7K

--198.84K

Special income (charges)

----

--0

--160.21K

-Less:Other special charges

----

---187.13K

-Gain on sale of business

----

--0

---26.93K

Other non- operating income (expenses)

----

--1.08K

----

Income before tax

-669.18%-9.44M

808.59K

1.66M

-112.07%-2.68M

-1.26M

Income tax

Net income

-669.18%-9.44M

808.59K

1.66M

-112.07%-2.68M

-1.26M

Net income continuous Operations

-669.18%-9.44M

--808.59K

--1.66M

-112.07%-2.68M

---1.26M

Minority interest income

Net income attributable to the parent company

-669.18%-9.44M

808.59K

1.66M

-112.07%-2.68M

-1.26M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-669.18%-9.44M

808.59K

1.66M

-112.07%-2.68M

-1.26M

Basic earnings per share

-538.96%-3.38

0.3731

0.77

-112.07%-1.2377

-0.5836

Diluted earnings per share

-1,790.00%-3.38

0.0944

0.2

-112.07%-1.2377

-0.5836

Dividend per share

Currency Unit

USD

	(Q1)Mar 31, 2024	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	-83.55%500K	3.04M
Operating revenue	--0	--0	--0	-83.55%500K	--3.04M
Cost of revenue
Gross profit
Operating expense	141.27%2.32M	945.54K	962K	-40.69%2.77M	4.67M
Selling and administrative expenses	105.73%1.22M	--473.36K	--593K	-0.68%1.29M	--1.3M
-General and administrative expense	105.73%1.22M	--473.36K	--593K	-0.68%1.29M	--1.3M
Research and development costs	177.19%1.11M	--479.19K	--399K	-58.59%1.57M	--3.8M
Other operating expenses	83.33%-5K	---7K	---30K	78.50%-91.5K	---425.57K
Operating profit	-141.27%-2.32M	-945.54K	-962K	-39.16%-2.27M	-1.63M
Net non-operating interest income expense	-15.12%-99K	-107.63K	-86K	-281.85%-14.12K	7.77K
Non-operating interest income	----	----	----	-83.82%1.76K	--10.86K
Non-operating interest expense	15.12%99K	--195.7K	--86K	413.19%15.88K	--3.09K
Other net income (expense)	-359.31%-7.02M	1.86M	2.71M	-210.75%-397.62K	359.04K
Gain on sale of security	-359.31%-7.02M	--1.86M	--2.71M	-300.52%-398.7K	--198.84K
Special income (charges)	----	----	----	--0	--160.21K
-Less:Other special charges	----	----	----	----	---187.13K
-Gain on sale of business	----	----	----	--0	---26.93K
Other non- operating income (expenses)	----	----	----	--1.08K	----
Income before tax	-669.18%-9.44M	808.59K	1.66M	-112.07%-2.68M	-1.26M
Income tax
Net income	-669.18%-9.44M	808.59K	1.66M	-112.07%-2.68M	-1.26M
Net income continuous Operations	-669.18%-9.44M	--808.59K	--1.66M	-112.07%-2.68M	---1.26M
Minority interest income
Net income attributable to the parent company	-669.18%-9.44M	808.59K	1.66M	-112.07%-2.68M	-1.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-669.18%-9.44M	808.59K	1.66M	-112.07%-2.68M	-1.26M
Basic earnings per share	-538.96%-3.38	0.3731	0.77	-112.07%-1.2377	-0.5836
Diluted earnings per share	-1,790.00%-3.38	0.0944	0.2	-112.07%-1.2377	-0.5836
Dividend per share
Currency Unit	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall